Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer
G Jian, Z Songwen, Z Ling, D Qinfang, Z Jie… - Journal of cancer …, 2010 - Springer
Purpose Recently, mutations in the epidermal growth factor receptor (EGFR) gene were
reported to correlate with EGFR tyrosine kinase inhibitor response in advanced non-small …
reported to correlate with EGFR tyrosine kinase inhibitor response in advanced non-small …
[引用][C] Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer
GUO JIAN, Z SONGWEN, Z LING… - Journal of cancer …, 2010 - pascal-francis.inist.fr
Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to
efficacy of gefitinib treatment in advanced non-small cell lung cancer CNRS Inist Pascal-Francis …
efficacy of gefitinib treatment in advanced non-small cell lung cancer CNRS Inist Pascal-Francis …
Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer
G Jian, Z Songwen, Z Ling, D Qinfang, Z Jie… - Journal of Cancer …, 2010 - infona.pl
Purpose Recently, mutations in the epidermal growth factor receptor (EGFR) gene were
reported to correlate with EGFR tyrosine kinase inhibitor response in advanced non-small …
reported to correlate with EGFR tyrosine kinase inhibitor response in advanced non-small …
Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer
G Jian, Z Songwen, Z Ling… - Journal of cancer …, 2010 - pubmed.ncbi.nlm.nih.gov
Purpose Recently, mutations in the epidermal growth factor receptor (EGFR) gene were
reported to correlate with EGFR tyrosine kinase inhibitor response in advanced non-small …
reported to correlate with EGFR tyrosine kinase inhibitor response in advanced non-small …
Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer.
G Jian, Z Songwen, Z Ling, D Qinfang… - Journal of Cancer …, 2010 - search.ebscohost.com
Recently, mutations in the epidermal growth factor receptor (EGFR) gene were reported to
correlate with EGFR tyrosine kinase inhibitor response in advanced non-small cell lung …
correlate with EGFR tyrosine kinase inhibitor response in advanced non-small cell lung …
Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer.
G Jian, Z Songwen, Z Ling, D Qinfang, Z Jie… - Journal of Cancer …, 2010 - europepmc.org
Purpose Recently, mutations in the epidermal growth factor receptor (EGFR) gene were
reported to correlate with EGFR tyrosine kinase inhibitor response in advanced non-small …
reported to correlate with EGFR tyrosine kinase inhibitor response in advanced non-small …
[引用][C] Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer
G Jian, Z Songwen, Z Ling, D Qinfang, Z Jie… - Journal of Cancer …, 2010 - cir.nii.ac.jp
Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to
efficacy of gefitinib treatment in advanced non-small cell lung cancer | CiNii Research CiNii …
efficacy of gefitinib treatment in advanced non-small cell lung cancer | CiNii Research CiNii …
Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer
G Jian, Z Songwen, Z Ling, D Qinfang… - Journal of Cancer …, 2010 - search.proquest.com
Recently, mutations in the epidermal growth factor receptor (EGFR) gene were reported to
correlate with EGFR tyrosine kinase inhibitor response in advanced non-small cell lung …
correlate with EGFR tyrosine kinase inhibitor response in advanced non-small cell lung …